Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FOOPAS Study: Functional Assessment and Prognostic Value in Aortic Valve Replacement for Patients ≥ 75 Years.

Journal of clinical medicine·2026
Same author

[Geriatric care assistance in emergency departments: position paper of DGIIN, DGINA, and DGG].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

Parker Mobility Score as a Screening Tool for Sarcopenia in Older German Adults: A Cross-Sectional Analysis of Trial Data.

Health science reports·2026
Same author

Influencing Factors and Participation in Ward Rounds for Geriatric Patients: A Descriptive Study Including Practical Guide for Optimization.

Journal of applied gerontology : the official journal of the Southern Gerontological Society·2026
Same author

Using Boomwhackers in geriatrics : A pilot study on well-being in patients with mental health problems including dementia.

Zeitschrift fur Gerontologie und Geriatrie·2025
Same author

The prevalence of sarcopenia and sarcopenic obesity in a German geriatric day clinic.

The Journal of frailty & aging·2025
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Chronic heart failure].

Markus Gosch1

  • 1Abteilung für Innere Medizin und Akutgeriatrie, Landeskrankenhaus Hochzirl, Anna Dengel Haus, Hochzirl, Austria. markus.gosch@tilak.at

Therapeutische Umschau. Revue Therapeutique
|August 5, 2008
PubMed
Summary
This summary is machine-generated.

Chronic heart failure increasingly affects older adults, often leading to frailty. Peripheral myopathy is a key factor, suggesting targeted therapies and exercise are crucial for managing this condition.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Jul 3, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

  • Geriatrics
  • Cardiology
  • Pathophysiology

Context:

  • Increasing life expectancy leads to a rise in chronic heart failure (CHF) patients, particularly among the elderly.
  • Frailty is a significant clinical concern in geriatric medicine and is often associated with CHF.
  • A weak correlation between functional capacity and cardiological findings in CHF patients prompted the development of the peripheral myopathy model.

Purpose:

  • To explore the link between chronic heart failure and frailty.
  • To investigate the pathophysiological mechanisms underlying exercise intolerance in CHF patients.
  • To discuss potential therapeutic strategies for frailty in the context of CHF.

Summary:

  • Chronic heart failure contributes to frailty, especially in the elderly population.
  • The model of peripheral myopathy in CHF helps explain exercise intolerance.
  • Therapeutic approaches include optimizing CHF treatment with ACE inhibitors and beta-blockers, alongside tailored endurance and strength training.

Impact:

  • Highlights the importance of addressing frailty in CHF management.
  • Suggests peripheral myopathy as a target for therapeutic interventions.
  • Emphasizes a combined approach of pharmacological treatment and exercise for CHF patients.